WILMINGTON, Mass.--(BUSINESS WIRE)--Sirtex, a leading developer of targeted and innovative cancer therapies, will sponsor a series of educational breakfast symposia at the 2007 American Hepato-Pancreato-Biliary Association (AHPBA) Annual Meeting to be held April 19-22 at the Bally’s Las Vegas in Las Vegas, Nev. Sirtex manufactures SIR-Spheres microspheres, the only FDA-approved microsphere therapy for metastatic colorectal cancer that has spread to the liver.1
